Fenwick & West has advised Maven Robotics. Maven Robotics, an AI robotics company, has raised $100 million in its Series A funding round. The investment will...
Maven Robotics Secures $100 Million in Series A Funding
Muon Space Secures $250 Million in Series C Funding
Fenwick & West has advised Muon Space. Muon Space has closed a $250 million Series C funding round, bringing its total equity funding to more than...
Ivo Secures $55 Million Series B Funding to Enhance AI Contract Intelligence Platform
Fenwick & West has advised Ivo. Ivo, an AI-powered contract intelligence platform serving in-house legal teams, has completed a $55 million Series B funding round. The...
Evident Vascular’s Series B Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Evident Vascular in the transaction. Evident Vascular, a medical technology company developing a best-in-class intravascular ultrasound (IVUS) platform...
QuEra Computing’s $230 Million Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented QuEra Computing in the transaction. QuEra Computing, a leader in neutral-atom quantum computing, announced raising $230 million in...
Evident Vascular’s $35 Million Series A Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Evident Vascular in the transaction. Evident Vascular announced it has launched its $35 million Series A financing led by Vensana...
Headway’s $125 Million Series C Financing Round
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Spark Capital in the transaction. The healthcare tech startup, Headway announced it has raised $125 million in Series C...
TCV Lead Instawork’s $60M Series D Financing
Gunderson Dettmer represented client TCV on the deal. Instawork, the leading platform for connecting businesses with skilled hourly workers, has announced it has raised $60 million in...
Photys Therapeutics’ $75 Million Series A Financing
Gunderson Dettmer advised Photys Therapeutics on the deal. Photys Therapeutics, a developer of phosphorylation-inducing chimeric small molecule (PHICS) medicines, announced its $75 million Series A financing...
Afresh’s $115 Million Series B Financing
Gunderson Dettmer represented Spark Capital on the deal. Spark Capital led the $115 million Series B financing of Afresh, an AI-powered fresh food technology provider that...
Carbon Biosciences’ $38 Million Series A Financing
Gunderson Dettmer represented Carbon Biosciences on the deal. Carbon Biosciences, a developer of novel parvovirus-derived gene therapies, announced its emergence from stealth mode and the closing of...